Oracle Investment Management Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Oracle Investment Management Inc
CRD #138127
SEC #801-73596
CIK #0001012622, 0001341439
AUM
Employees 4 (75% Investors, 0% Brokers)
Fees
Minimum
Phone203-862-7900
Address177 W Putnam Avenue
Greenwich, CT 06902
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
120096072048024002010201520212027
Fees and Compensation — Form ADV Part 2A (4/3/2023) [Brochure]
Item 5            Fees and Compensation
As investment adviser to the Funds, Oracle receives a management fee in accordance with each Fund’s
confidential private offering memorandum, which is generally based on assets under management. Below is a
summary of the fee structure for each of the funds currently managed by Oracle:
        OP & OIP: Oracle receives a management fee at an annual rate of up to 1.5% - 2% of the value of the
         net assets of the Funds, as of the first business day of each fiscal quarter. The management fee is
         payable in advance, as of the first day of each fiscal quarter. Management fees, with respect to
         contributions made on a day other than the first day of a fiscal quarter, will be pro-rated. Management
         fees, with respect to redemptions made on a day other than the last day of a fiscal quarter, will be
         returned for payment or credited to the redeeming Investor.
        TEN: Oracle receives a management fee at an annual rate of up to 1.5% - 2% of the month-end capital
         account balance of each Limited Partner. This fee, payable quarterly in arrears, is charged to each
         Limited Partner’s Capital balance, as of the first day of the following month.
The Funds pay these fees by debiting the accounts of investors in each given Fund, as applicable. Investors do
not have the option to be billed directly for the fees incurred. Management fees are generally not negotiable;
however, Oracle maintains the right to waive or modify the management fees for investors of the Fund that are
the Principals, members, employees or affiliates of Oracle (or General Partner, as applicable), members of the
immediate families of such persons, and for certain large or strategic investors.

Item 4 Advisory Business                                                                              Page 3 of 14

Oracle Investment Management, Inc. | Form ADV Part 2A Brochure| March 2023                     Back to Table of Contents

The Funds pay for organizational and initial offering expenses as well as ongoing operating expenses, including
but not limited to accounting, auditing, bank fees, tax preparation, legal, administration, research, and trading
costs. The Funds also incur brokerage and other transaction costs. For further detail, including Soft Dollar use,
within and outside of Section 28E of the Securities Act of 1934, please refer to the Soft Dollar detail Item 12:
Brokerage Practices (pg 11) of this Brochure.

Expenses incurred for the benefit of one or more Clients are generally allocated pro-rata in proportion to the
relative net asset value of each of such Clients or any other manner Oracle determines to be fair and reasonable
in light of the circumstances, taking account of what is practicable.

Oracle and its employees do not accept compensation, including sales charges or service fees, from any person
for the sale of securities or other investment products.
Account Minimums and Types of Clients — Form ADV Part 2A (4/3/2023) [Brochure]
Item 7            Types of Clients
The Firm’s Clients are the Funds. Investors in the Funds consist primarily of institutional investors, high net
worth individuals, and family offices.

The minimum initial investment for each Fund is as follows:
        Oracle Partners, L.P.                        US $ 2 million
        Oracle Institutional Partners, L.P.          US $ 1 million
        Oracle Ten Fund, L.P.                        US $ 1 million

Item 6 Performance-Based Fees & Side-By-Side Management                                                  Page 4 of 14

Oracle Investment Management, Inc. | Form ADV Part 2A Brochure| March 2023                                             Back to Table of Contents
Sector Form 13F Holdings Value ($B)
CM Life Sciences Inc 0.1
Ardelyx Inc 0.0
Biohaven Ltd 0.0
Quidelortho Corp 0.0
Personalis Inc 0.0
Teladoc Inc 0.0
Taysha Gene Therapies Inc 0.0
CAVA Group Inc 0.0
Edgewise Therapeutics Inc 0.0
Biogen IDEC Inc 0.0
View All
Holdings by Sector ($B)
15012090603002011201620212027
Type Form D Funds Date Sold AUM
HF Oracle Ten Fund LP 2019-03-29 16.7 M
HF Oracle Institutional Partners LP 2012-02-14 18.4 M
HF Oracle Offshore Limited 2012-02-14 11.4 M
HF Oracle Partners LP 2012-02-14 174.1 M
HF Oracle Ten Fund Master LP 2012-02-14 137.0 M
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 209.1
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 209.1
By Discretionary
Discretionary 3 209.1
Non-Discretionary 0 0.0
Total 3 209.1
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 209.1
Total 3 209.1
EDGAR Form CIK 2011 - 2026
13F-HR [0001012622]
3 [0001012622]
4 [0001012622]
10-K [0001341439]
10-Q [0001341439]
3 [0001341439]
4 [0001341439]
8-K [0001341439]
SC 13D [0001341439]
SC 13G [0001341439]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Oracle Corp [2018-02-09]
BlackRock Inc Oracle Corp [2018-02-08]
Oracle Corp Netsuite Inc [2016-08-12]
Oracle Corp Opower Inc [2016-05-12]
Oracle Corp Textura Corp [2016-05-10]
Oracle Corp Responsys Inc [2013-12-31]
Oracle Corp ACME Packet Inc [2013-02-13]
Oracle Corp Eloqua Inc [2012-12-27]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI254900MY3GRHAO1BKI91
Form 3/4/5 Subject 2011 - 2026
Oracle Corp
Henley Jeffrey
Boskin Michael J
Mihaljevic Tomislav
Fairhead Rona Alison
Chizen Bruce R
Berg Jeffrey
Ablo Awo
Rusckowski Stephen H
Moorman Charles W
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Oracle Corp ORCL
Common Stock
2026-02-09 Sell 10,000 $155.23 1,552,300
Oracle Corp ORCL
Restricted Stock Unit · derivative
2026-01-23 Grant 337.78 $177.16 59,841
Oracle Corp ORCL
Common Stock
2026-01-15 Sell 35,000 $194.89 6,821,150
Oracle Corp ORCL
Common Stock
2025-12-24 Sell 15,000 $196.89 2,953,350
Oracle Corp ORCL
Common Stock
2025-12-23 Other 199,071 $0.00
Oracle Corp ORCL
Common Stock
2025-12-23 Sell 2,223 $196.61 437,064
Oracle Corp ORCL
Common Stock
2025-12-22 Gift 5,000 $0.00
Oracle Corp ORCL
Common Stock
2025-12-19 Sell 10,000 $192.52 1,925,200
Oracle Corp ORCL
Common Stock
2025-12-05 Tax withheld 5,740 $214.33 1,230,254
Oracle Corp ORCL
Common Stock
2025-12-05 Option exercise 11,016 $0.00
Oracle Corp ORCL
Restricted Stock Unit · derivative
2025-12-05 Option exercise 11,016 $0.00
Oracle Corp ORCL
Restricted Stock Unit · derivative
2025-11-18 Grant 793 $0.00
Oracle Corp ORCL
Common Stock
2025-10-28 Sell 4,226 $284.31 1,201,494
Oracle Corp ORCL
Common Stock
2025-10-28 Sell 13,373 $282.56 3,778,675
Oracle Corp ORCL
Common Stock
2025-10-28 Sell 9,042 $281.58 2,546,046
Oracle Corp ORCL
Common Stock
2025-10-28 Sell 22,724 $283.63 6,445,208
Oracle Corp ORCL
Restricted Stock Unit · derivative
2025-10-23 Grant 142.94 $280.07 40,033
Oracle Corp ORCL
Stock Option · derivative
2025-10-23 Grant 428,465 $0.00
Oracle Corp ORCL
Restricted Stock Unit · derivative
2025-10-23 Grant 35,706 $0.00
Oracle Corp ORCL
Restricted Stock Unit · derivative
2025-10-23 Grant 32,135 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com